![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Long acting injectable cabotegravir: updated efficacy and safety results from HPTN 084
|
|
|
AIDS 2022 July 29- Aug 1 Montreal
S Delany-Moretlwe, JP Hughes, P Bock, S Dadabhai, D Gadama, P Hunidzarira, S Innes, D Kalonji, J Makhema, P Mandima, C Mathew, J Mpendo, P Mukwekwerere, N Mgodi, P Nahirya Ntege, C Nakabiito, H Nuwagaba-Biribonwoha, R Panchia, F Angira, N Singh, B Siziba, E Spooner, J Farrior, S Rose, R Berhanu, Y Agyei, SH Eshleman, M Marzinke, E Piwowar-Manning, S Beigel-Orme, S Hosek, A Adeyeye, J Rooney, A Rinehart, B Hanscom, M Cohen, M Hosseinipour
on behalf of the HPTN 084 study team
![0730221opy](../images/073022/073022-2/0730221opy.gif)
![0730222copy](../images/073022/073022-2/0730222copy.gif)
![0730223copy](../images/073022/073022-2/0730223copy.gif)
![0730224copy](../images/073022/073022-2/0730224copy.gif)
![0730225copy](../images/073022/073022-2/0730225copy.gif)
![0730226copy](../images/073022/073022-2/0730226copy.gif)
![0730227copy](../images/073022/073022-2/0730227copy.gif)
![0730228copy](../images/073022/073022-2/0730228copy.gif)
![0730229copy](../images/073022/073022-2/0730229copy.gif)
![07302210copy](../images/073022/073022-2/07302210copy.gif)
![07302211copy](../images/073022/073022-2/07302211copy.gif)
![07302212copy](../images/073022/073022-2/07302212copy.gif)
![07302214copy](../images/073022/073022-2/07302214copy.gif)
![07302215copy](../images/073022/073022-2/07302215copy.gif)
![07302216copy](../images/073022/073022-2/07302216copy.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|